cell-cycle specificity

Cell-cycle specificity describes whether a chemotherapy drug only works while a cell is at a particular stage of dividing. A dividing cell passes through phases like a factory shift: it grows, copies its DNA, prepares to split, and then splits. Some drugs can only do damage during one of these phases; others can strike a cell at any time, even when it is resting.

Cell-cycle-specific (also called phase-specific) drugs act on cells only during a defined phase. Antimetabolites mostly hit during S phase, when DNA is being copied; antimitotics hit during M phase, when the cell physically divides. Cell-cycle-nonspecific drugs, such as alkylating agents and many topoisomerase II inhibitors, can damage DNA in cells regardless of phase, including cells that are not currently dividing. This distinction strongly shapes how each drug is scheduled.

The practical consequence is dosing strategy. Phase-specific drugs catch only the fraction of cells passing through the right phase at the time, so they are often given as repeated or prolonged exposure to capture more cells over time. Nonspecific drugs may show more dose-proportional killing in a single exposure. Real treatment regimens are built partly around these kinetics, though tumour heterogeneity and resting cell populations complicate the neat picture.